We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $69.6B
1-Year Est. Return 42.52%
This Fund
S&P 500
This Quarter Est. Return
+6.39%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$35B
AUM Growth
+$1.68B
Cap. Flow
-$65.3M
Cap. Flow %
-0.19%
Top 10 Hldgs %
25.99%
Holding
2,270
New
182
Increased
804
Reduced
958
Closed
157

Sector Composition

Rank Sector Weight
1 Healthcare 15.78%
2 Consumer Staples 13.66%
3 Utilities 10.28%
4 Communication Services 10.13%
5 Technology 9.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TCBI icon
876
Texas Capital Bancshares
TCBI
$4.14B
$2.17M 0.01%
25,961
+24,326
+1,488% +$2.04M
BGC
877
DELISTED
General Cable Corporation
BGC
$2.16M 0.01%
120,326
+4,882
+4% +$87.5K
WRI
878
DELISTED
Weingarten Realty Investors
WRI
$2.15M 0.01%
64,366
-644
-1% -$22.5K
CDP icon
879
COPT Defense Properties
CDP
$3.89B
$2.14M 0.01%
64,708
-228
-0.4% -$7.44K
GWR
880
DELISTED
Genesee & Wyoming Inc.
GWR
$2.14M 0.01%
31,546
+288
+0.9% +$20.8K
UMPQ
881
DELISTED
Umpqua Holdings Corp
UMPQ
$2.14M 0.01%
120,517
-20,334
-14% -$374K
LM
882
DELISTED
Legg Mason, Inc.
LM
$2.14M 0.01%
59,187
-3,838
-6% -$133K
EPC icon
883
Edgewell Personal Care
EPC
$1.23B
$2.13M 0.01%
29,114
-2,126
-7% -$162K
SPLS
884
DELISTED
Staples Inc
SPLS
$2.12M 0.01%
242,186
+31,646
+15% +$285K
BCRX icon
885
BioCryst Pharmaceuticals
BCRX
$2.15B
$2.12M 0.01%
252,060
+168,225
+201% +$1.17M
DST
886
DELISTED
DST Systems Inc.
DST
$2.11M 0.01%
34,522
+202
+0.6% +$11.7K
FE icon
887
FirstEnergy
FE
$26.3B
$2.11M 0.01%
66,330
-155,480
-70% -$4.8M
HAIN icon
888
Hain Celestial
HAIN
$53.2M
$2.1M 0.01%
56,526
+12,603
+29% +$474K
PTLA
889
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$2.1M 0.01%
+53,450
New +$1.7M
EHC icon
890
Encompass Health
EHC
$12.2B
$2.09M 0.01%
61,236
-1,224
-2% -$40.2K
CS
891
DELISTED
Credit Suisse Group
CS
$2.08M 0.01%
140,505
+140,000
+27,723% +$2.14M
BIO icon
892
Bio-Rad Laboratories Class A
BIO
$10.1B
$2.08M 0.01%
10,453
+1,833
+21% +$353K
CLDX icon
893
Celldex Therapeutics
CLDX
$3.04B
$2.08M 0.01%
38,460
+3,211
+9% +$167K
RBCAA icon
894
Republic Bancorp
RBCAA
$1.85B
$2.08M 0.01%
60,431
+10,775
+22% +$385K
FR icon
895
First Industrial Realty Trust
FR
$8.14B
$2.08M 0.01%
77,926
+15,996
+26% +$428K
MSFG
896
DELISTED
MainSource Financial Group Inc
MSFG
$2.08M 0.01%
63,004
+7,708
+14% +$257K
HAL icon
897
Halliburton
HAL
$28.8B
$2.07M 0.01%
42,100
+1,319
+3% +$70.9K
THC icon
898
Tenet Healthcare
THC
$21.4B
$2.07M 0.01%
116,874
-15,454
-12% -$287K
AES icon
899
AES
AES
$10.6B
$2.07M 0.01%
184,949
+21,479
+13% +$245K
OZK icon
900
Bank OZK
OZK
$5.23B
$2.06M 0.01%
39,712
-9,651
-20% -$519K

Similar funds

Federated Hermes's Q1 2017 Portfolio in Review

As of Q1 2017, Federated Hermes held 2,270 positions worth $35B, up 5% from $33.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Federated Hermes's Q1 2017 filing shows 182 new, 804 increased, 958 reduced and 157 closed positions. Its largest new stake was Marvell Technology: 2,641,573 shares worth $40.3M. The largest sale was Johnson & Johnson, an estimated $247M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Consumer Staples and Utilities.

  • Federated Hermes's largest Q1 2017 buy was Marvell Technology: 2,641,573 shares worth $40.3M.
  • Federated Hermes added most to Occidental Petroleum in Q1 2017, an estimated $143M increase.
  • Federated Hermes's biggest Q1 2017 reduction was Johnson & Johnson, cutting an estimated $247M.
  • Federated Hermes fully exited Unilever in Q1 2017, selling an estimated $111M.
  • Federated Hermes's ten largest holdings make up 26% of its $35B portfolio in Q1 2017.
  • Federated Hermes opened 182 new positions and closed 157 in Q1 2017.
  • Federated Hermes's portfolio value rose 5% quarter-over-quarter to $35B.

Based on Federated Hermes's 13F filing for Q1 2017, filed 12 May 2017.